Conference abstract · 8 Sep 2014
Conference abstractPublished 8 Sep 2014
Implementation of changes aligned to regulatory framework
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Despite having specific role of a manufacturing unit of any Pharmaceutical company with its regulatory function, still there is a close connection between the functions and for smooth operation both the functions should act simultaneously to meet the diversified requirement of various regulatory authorities in a timely manner irrespective of region or country. The most challenging situation for the manufacturing or technical operations unit is to incorporate relevant changes planned or unplanned or to incorporate frequent update done by different pharmacopoeial bodies or even by suppliers. Challenge may not be serious for the first time dossier submission as there are scopes to include everything then; however, it might have impact specially for interim variation submission due to process change or improvement, alternate source development for any API or excipients or packaging material, batch scale up or machine change or change of analytical method or specification followed by questions to be handled on relevant stability studies for the change already implemented or the requirement of BE studies if required. For all the cases, Tech Ops function has to be aligned with the stipulated changes and to make sure documentation and its quality required for updating the respective dossier. Submission of a dossier for the first time is completely different than to the maintenance work related to handle deficiency queries subsequently asked by different regulatory bodies or Health authority for the already submitted dossier, since different body needs different requirement. Moreover, time line is a crucial barrier for filing up variation and it depends on specific country or regional regulatory set up, lack of which severe market shortage can happen. This paper presents a critical analysis of steps required for preparing dossier in CTD template, on time necessary document support to be provided by manufacturing unit to generate different modules and harmonization of critical changes to align with regulatory requirements e.g. for US market, EU or rest of the world.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 31 Mar 2025
Regulatory Affairs in Clinical Trials: Aligning Global Compliance with Ethical Research Standards
Editorial · 29 Sep 2025
Regulatory Aspects of Nanopharmaceuticals: Challenges and Frameworks for Safe Innovation
Article · 26 Jun 2024
Ethical Considerations and Regulatory Frameworks for AI in the Pharmaceutical Industry
Commentary · 29 May 2024
The Influence of Regulatory Frameworks on Sustainable Innovation in Biopharma
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mohammad Iqbal Hossain”

